Desmopressin and super platelets

Blood

Volumn 123, Issue 12, 2014, Pages 1779-1780

  Pecci, Alessandro ^a   Balduini, Carlo L ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONVULXIN; DESMOPRESSIN; PROCOAGULANT; THROMBIN; THROMBOSPONDIN; VON WILLEBRAND FACTOR;

BERNARD SOULIER DISEASE; BLOOD VESSEL INJURY; BONE MARROW DEPRESSION; ENDOTHELIUM CELL; GLANZMANN DISEASE; HEMOSTASIS; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIA;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; DEAMINO ARGININE VASOPRESSIN; FEMALE; HUMANS; MALE;

EID: 84897529451     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-01-551242     Document Type: Note

References (10)

1. Colucci G, Stutz M, Rochat S, et al. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT-platelets in patients with primary platelet function defects. Blood. 2014;123(12):1905-1916.
2. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977;1(8017):869-872. (Pubitemid 8079684)
3. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood. 1997;90(7):2515-2521. (Pubitemid 27413458)
4. Castaman G, Bona ED, Schiavotto C, Trentin L, D'Emilio A, Rodeghiero F. Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. Haematologica. 1997;82(5):584-587. (Pubitemid 28023254)
5. Reiter RA, Mayr F, Blazicek H, et al. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood. 2003;102(13):4594-4599. (Pubitemid 37494129)
6. Noris P, Arbustini E, Spedini P, Belletti S, Balduini CL. A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) Ib and severely reduced amounts of GPIX and GPV. Br J Haematol. 1998;103(4):1004-1013. (Pubitemid 29012636)
7. Balduini CL, Noris P, Belletti S, Spedini P, Gamba G. In vitro and in vivo effects of desmopressin on platelet function. Haematologica. 1999;84(10):891-896. (Pubitemid 29516919)
8. Tosetto A, Balduini CL, Cattaneo M, et al Italian Society for Haemostasis and Thrombosis. Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res. 2009;124(5):e13-e18.
9. Dale GL, Friese P, Batar P, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002;415(6868):175-179. (Pubitemid 34059519)
10. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356(22):2301-2311. (Pubitemid 46849160)